Treatment of cutaneous T cell lymphoma.
Department of Dermatology, Yale University School of Medicine, New Haven, Conn.
R L
RL
Edelson
D058892:Adenosine Deaminase Inhibitors; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003131:Combined Modality Therapy; D006801:Humans; D007370:Interferon Type I / Q000627:therapeutic use; D008223:Lymphoma / Q000628:therapy*; D011701:PUVA Therapy; D012176:Retinoids / Q000627:therapeutic use; D012878:Skin Neoplasms / Q000628:therapy*; D013601:T-Lymphocytes
D058892:Adenosine Deaminase Inhibitors; D000911:Antibodies, Monoclonal; D007370:Interferon Type I; D012176:Retinoids